HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Deutsche Bank AG

Key Points

• Deutsche Bank AG has reduced its stake in HCA Healthcare, Inc. by 3.8%, selling 21,358 shares during the first quarter, and now owns a total of 547,687 shares valued at approximately $189.25 million.
• HCA Healthcare's stock has been rated with a mix of opinions from analysts, including nine buy ratings and nine hold ratings, with an average target price of $395.69.
• The company declared a quarterly dividend of $0.72, with the payment scheduled for September 30th, reflecting a 0.8% dividend yield.

Deutsche Bank AG decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 547,687 shares of the company's stock after selling 21,358 shares during the quarter. Deutsche Bank AG owned about 0.23% of HCA Healthcare worth $189,253,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. GAMMA Investing LLC boosted its holdings in HCA Healthcare by 40,527.3% in the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. Pacer Advisors Inc. boosted its stake in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after buying an additional 1,329,618 shares during the last quarter. Goldman Sachs Group Inc. raised its position in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Barclays PLC boosted its position in HCA Healthcare by 85.7% in the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company's stock worth $318,727,000 after purchasing an additional 489,916 shares in the last quarter. Finally, Two Sigma Investments LP lifted its stake in shares of HCA Healthcare by 12,016.0% in the 4th quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock valued at $140,301,000 after purchasing an additional 463,579 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a report on Wednesday, July 16th. Morgan Stanley reduced their price target on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Finally, Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $395.69.

HCA Healthcare Trading Up 2.3%

NYSE HCA traded up $8.51 on Friday, reaching $381.84. 1,015,992 shares of the company were exchanged, compared to its average volume of 1,594,209. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The business's fifty day moving average price is $369.74 and its 200 day moving average price is $349.53. The stock has a market capitalization of $89.35 billion, a P/E ratio of 16.05, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.50 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.